Posted today in Medical

Many Doctors Silent on Cost of Cancer Care

Cancer doctors are often mute when a patient asks about the cost of treatment, a new study shows. Yet, such questions are critically important. Cancer patients are three times more likely to declare bankruptcy than people with other chronic ailments, and tight finances often lead patients to skip doses of medicine or drop out of treatment altogether,...

Posted today in Medical

Big Gap in Cancer Deaths Between Rich, Poor Countries

Over the past few decades, death rates linked to cancer and heart disease have declined in most developed nations, thanks to more effective prevention strategies, early detection and greater access to quality health care. But the same isn't true for poorer counties where the number of people dying from cancer has either remained unchanged or continues...

Posted 2 days ago in New Drug Approvals

Melinta Therapeutics Announces FDA Approval of Baxdela (delafloxacin) for Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

NEW HAVEN, Conn, June 19, 2017 – Melinta Therapeutics, a privately held company focused on discovering, developing, and commercializing novel antibiotics to treat serious bacterial infections, announced today that the U.S. Food and Drug Administration (FDA) has approved Baxdela (delafloxacin), indicated in adults for the treatment of acute bacterial...

Posted 2 days ago in New Drug Approvals

Neos Therapeutics Announces FDA Approval of Cotempla XR-ODT (methylphenidate) Extended-Release Orally Disintegrating Tablets for the Treatment of ADHD in Patients 6 to 17 Years Old

DALLAS and FORT WORTH, Texas, June 19, 2017 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq:NEOS), a pharmaceutical company focused on developing, manufacturing and commercializing innovative extended-release (XR) products using its proprietary modified-release drug delivery and orally disintegrating tablet (ODT) technologies, today announced that...

Posted 3 days ago in Clinical Trials

Pfizer Begins Phase 1 Clinical Trial to Evaluate Investigational Group B Streptococcus Vaccine

June 19, 2017 Pfizer Inc. (NYSE:PFE) today announced that it has started a Phase 1 trial in healthy volunteers of PF-06760805, an investigational vaccine designed to help protect against Group B Streptococcus (GBS) infection. An estimated 10 to 30 percent of pregnant women carry the GBS bacteria.1 In newborns, GBS manifests as sepsis, pneumonia, and...

Posted today in Medical

Health Tip: Want Healthier Lungs?

-- Though you can't live without them, we'll bet you haven't spent much time thinking about how to take care of your lungs. The American Lung Association has these suggestions: Don't start smoking; if you are a smoker, quit. Don't allow smoking in your home or car. Test your home for radon. Avoid the outdoors when air quality is poor. Prevent lung...

Posted today in Medical

Health Tip: Get the Facts on Alcohol and Sleep

-- A glass of wine may initially help you drift off to sleep, but it's hardly a prescription for a quality night of rest. Here's how alcohol can interfere with sleep, according to the National Sleep Foundation: Alcohol's iniitial sedating effects wear off, which could make you more restless and likely to waken. Alcohol interferes with REM sleep, which...

Posted today in Medical

Most U.S. Teens Aren't 'Doing It'

Sex is everywhere in the media, and so you may be convinced that today's teens are always looking to "hook-up." But new federal research says it's just not so. Instead, the study found that most teenagers in high school aren't sexually active. "The myth is that every kid in high school is having sex, and it's not true," noted Dr. Cora Breuner, a professor...

Posted today in Medical

Could Your Office Job Rob You of Vitamin D?

Spending your days cooped up inside an office might mean you're not getting enough vital vitamin D -- know as the "sunshine vitamin," researchers report. Canadian researchers found that vitamin D deficiency levels differ by occupation, with people who are closeted indoors faring worse than others. "We know that vitamin D deficiency and insufficiency...

Posted today in Medical

Secondhand Smoke Still Plagues Some Cancer Survivors

The number of nonsmoking cancer survivors exposed to secondhand smoke is down significantly in the United States, but it's too soon to breathe easy. A new review of federal data on nearly 700 nonsmoking adult cancer survivors found 15.7 percent reporting exposure to secondhand smoke in 2011-2012, down from nearly 40 percent in 1999-2000. However, exposure...

Recently added consumer and prescribing information: Baxdela, Imfinzi, Radicava, Kevzara, Tymlos, Rydapt, Alunbrig, Ingrezza, Austedo, Ocrevus

Posted in Blog

Drugs.com Recognized as ‘Health Information Website Brand of the Year’ in 2017 Harris Poll EquiTrend® Study

The team at Drugs.com is humbled and heartened to have been recognized as the ‘Health Information Website Brand of the Year‘ in the 2017 Harris Poll EquiTrend Study. The annual Harris Poll EquiTrend® Study measures and compares a brand’s health over time and against key competitors. Other categories measured include travel, financial, automotive and entertainment. […]

Posted in Blog

REMS@FDA: An Upgraded Patient Safety Program

REMS Overview Fact: Prescription drugs are complicated, and they are getting more complicated every day. Issues with complex drugs and side effects is not just a concern for the healthcare provider, it directly impacts the patient and caregiver, too. We’ve all heard the long list of adverse effects and warnings that unfold during a primetime […]

Posted in Blog

Drugs.com the First Major Consumer Health Publisher to Implement Full HTTPS Encryption

Drugs.com is pleased to announce the introduction of full HTTPS encryption for all web site visitors. With this significant and important change, nearly 70 million monthly visitors will have access to critical health and medicine information in a safe, secure and private environment. Why HTTPS Encryption? Almost everything you do on the Internet leaves a digital […]